Article

Companies ink deal for anti-bacterial lenses

Sydney, Australia –Biosignal Ltd. and the Institute for Eye Research have signed an agreement with what they are calling "a major contact lens manufacturer" to develop an anti-bacterial daily disposable and other frequent-replacement contact lenses for release in the United States and Europe

Sydney, Australia–Biosignal Ltd. and the Institute for Eye Research have signed an agreement with what they are calling "a major contact lens manufacturer" to develop an anti-bacterial daily disposable and other frequent-replacement contact lenses for release in the United States and Europe.

The deal, inked as a "memorandum of understanding," includes the development of anti-bacterial contact lenses that would prevent contact-lens wearers from getting eye infections. Daily disposable contact lenses represent a new segment for Biosignal and complement the development of anti-bacterial extended-wear lenses, the company noted.

Biosignal will fund research and development of anti-bacterial extended-wear lenses, and it will have exclusive negotiation rights during that 16-month phase to use the technology as the basis for a future royalty agreement. Final testing under the R&D agreement will be done in a small, in-house human study in 2006, with the goal of launching anti-bacterial, daily disposable lenses within 2 or 3 years.

It is based on anti-biofilm technology that was developed after it was discovered that the eastern Australian seaweed Delisea pulchra produced natural furanones that disable bacteria's ability to colonize.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.